Pooja Pal

Title: Pooja Pal: Innovator in Anti-Leukemic Research

Introduction

Pooja Pal is a notable inventor based in Lucknow, India. She has made significant contributions to the field of medical research, particularly in the development of anti-leukemic agents. Her work focuses on inducing differentiation in myeloid leukemia cells, which is crucial for advancing treatment options for this type of cancer.

Latest Patents

Pooja Pal holds a patent for an anti-leukemic agent that is useful for inducing differentiation in myeloid leukemia cells. The patent describes the compound Ormeloxifene, which is effective in treating various forms of myeloid leukemia, including acute promyelocytic leukemia, acute myeloid leukemia, and chronic myeloid leukemia. The invention highlights how Ormeloxifene induces differentiation, marked by an increase in differentiation marker proteins and surface proteins. The research indicates that differentiated cells exhibit neutrophil-like morphology when treated with specific doses of Ormeloxifene, demonstrating its potential in leukemia treatment.

Career Highlights

Pooja Pal is affiliated with the Council of Scientific & Industrial Research, where she conducts her research. Her innovative work has led to advancements in understanding how to combat myeloid leukemia through differentiation induction.

Collaborations

Pooja has collaborated with colleagues such as Savita Lochab and Jitendra Kumar Kanuajiya, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Pooja Pal's contributions to anti-leukemic research exemplify the impact of innovative thinking in medicine. Her patent on Ormeloxifene represents a significant step forward in the treatment of myeloid leukemia, showcasing her dedication to improving patient outcomes.